Fisher & Paykel Healthcare has reported record full-year revenue of over $2 billion for the first time in its history.
Total operating revenue for the financial year ended March 31, 2025, was $2.02 billion, a 16% increase from the previous year.
The growth was driven by strong demand for hospital consumables and masks for treating obstructive sleep apnea.
Net profit after tax also increased by 43% to $377.2 million.
The company's hospital product group generated $1.28b in revenue, up 18%, while the homecare product group had a 13% increase in revenue to $739.9m.
Fisher & Paykel Healthcare expects full-year operating revenue in the range of $2.15b-$2.25b and net profit after tax of $390m-$440m for the 2026 financial year.
See more
